Drawing for GENODYSSEE

USPTO serial 76167648

GENODYSSEE

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
BUSH, KAREN K
Law office
FILE REPOSITORY (FRANCONIA)

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with GENODYSSEE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Neil F Greenblum

NEIL F GREENBLUM AND BRUCE H BERNSTEIN GREENBLUM & BERNSTEIN PLC1950 ROLAND CLARKE PLRESTON, VA 20191UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases, and cancer; products with a therapeutical advantage, namely, propolis for medicinal or therapeutic purposes; topical gel for medical and therapeutic use for the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases, and cancer; diagnosis and prognosis products for medical use, namely, diagnostic reagents for clinical or medical laboratory use; medication for human medicine, namely, cytokines growth factors, therapeutic proteins, and monoclonal antibodies for use in the treatment of infectious diseases, immune deficiencies, transplantation, multiple sclerosis, auto-immune diseases and cancerACTIVE—
016Instruction manuals in the field of chemistry, biology and biotechnology and genetics, computer instruction manuals sold separately, educational and reference books in the area of chemistry, biology, biotechnology and genetics, printed publication in the nature of printed reviews of pharmaceutical and diagnostic applications and genetic applications, newspapers of pharmaceutical and diagnostic application and genetic applicationsACTIVE—
035Computerized database managementACTIVE—
038Electronic transmission of data and documents via computer terminals, providing multiple-user access to a global computer information network, electronic transmission of data and documents via computer terminals, namely, broadcasting information via the worldwide communication networks, the Internet, and via restricted access Intranet networksACTIVE—
042Medical services, scientific research, medical and scientific diagnosis an analysis in the field of physical therapy, chemical and biological analysis, research in chemistry and biology, structural and functional analysis of genomes, conducting feasibility studies, namely, conducting studies in technical projects, product research and development, namely, developmental research studies in technical projects, developmental research of new products for third parties, technical assistanceACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Sep 29, 2004MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Sep 29, 2004ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 5, 2004CFITCASE FILE IN TICRS—
Apr 26, 2004DOCKASSIGNED TO EXAMINER—
Feb 18, 2004EX2GSOU EXTENSION 2 GRANTED—
Jan 28, 2004EXT2SOU EXTENSION 2 FILED—
Jan 28, 2004MAILPAPER RECEIVED—
Aug 19, 2003EX1GSOU EXTENSION 1 GRANTED—
Jul 21, 2003EXT1SOU EXTENSION 1 FILED—
Jul 21, 2003MAILPAPER RECEIVED—
Feb 4, 2003NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jan 29, 2003TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 12, 2002PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 23, 2002NPUBNOTICE OF PUBLICATION—
Aug 21, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 15, 2002CNEAEXAMINERS AMENDMENT MAILED—
Jun 12, 2002CNEAEXAMINERS AMENDMENT MAILED—
Jun 10, 2002DOCKASSIGNED TO EXAMINER—
Apr 23, 2002CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 18, 2002ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Mar 5, 2002CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 22, 2002CNEAEXAMINERS AMENDMENT MAILED—
Sep 19, 200144DDSEC. 44(D) CLAIM DELETED—
Sep 19, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 2, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 26, 2001DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance